Rare diseases
Investigational molecules
Locations
Back to Croatia257 clinical trials in Zagreb, Croatia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer
CroatiaStudy Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer
CroatiaStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
CroatiaStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
CroatiaStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
CroatiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
CroatiaStudy on Fenebrutinib for Patients with Relapsing Multiple Sclerosis
CroatiaStudy on the Effects of Barzolvolimab for Patients with Prurigo Nodularis
CroatiaStudy Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
CroatiaStudy on the Effectiveness and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam for Adults with Resistant Bacterial Infections
CroatiaStudy on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy
CroatiaStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on autoimmune disorders encompass treatments for psoriatic arthritis, Sjögren's Syndrome, and systemic lupus erythematosus, evaluating novel therapeutic approaches for improved patient outcomes.
These trials aim to assess new biological medicines and their effectiveness in managing chronic inflammatory conditions.
Research initiatives targeting neurological conditions focus on multiple sclerosis and Alzheimer's disease-related psychosis, exploring innovative treatment approaches for better disease management.
Studies evaluate both established and emerging treatments to improve patient outcomes and quality of life.
Advanced cancer research programs examine treatments for lung cancer, leukemia, and thyroid cancer, investigating targeted therapies and combination treatments.
These trials focus on improving survival rates and developing more effective treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
